Related Experiment Videos
[Innovative treatment in oncology]
Barbara Capaccetti1, Paola Bonginelli, Roberta Sarmiento
1Unità Operativa di Oncologia Medica, Azienda Complesso Ospedaliero di Rilevanza Nazionale San Filippo Neri, Roma.
Recenti Progressi in Medicina
|December 20, 2002
Summary
Understanding molecular mechanisms in cancer aids in identifying new anticancer therapies. Targeted compounds and reliable biomarkers are crucial for effective patient selection and treatment monitoring.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Advances in understanding cell transformation and tumor progression.
- Identification of novel therapeutic targets for cancer treatment.
Purpose of the Study:
- To highlight the importance of molecular mechanisms in identifying new anticancer therapeutic targets.
- To emphasize the need for surrogate markers in patient selection and monitoring of molecular-targeting compounds.
Main Methods:
- Review of current knowledge on molecular mechanisms in cancer.
- Discussion of molecular-targeting compounds (e.g., anti-angiogenesis, tyrosine kinase inhibitors).
Main Results:
- Improved knowledge of molecular mechanisms facilitates the discovery of new therapeutic targets.
- Development of molecular-targeting compounds offers selective interference with tumor growth.
Conclusions:
- Rationale patient selection and pharmacodynamic monitoring require accessible surrogate markers.
- Biomarkers in tumor tissue or blood are essential for personalized cancer therapy.